Mrs Chhanda Beckford, CRNA | |
80th St & 41st Ave, Elmhurst, NY 11373-1329 | |
(718) 334-5970 | |
(718) 334-5958 |
Full Name | Mrs Chhanda Beckford |
---|---|
Gender | Female |
Speciality | Certified Registered Nurse Anesthetist (crna) |
Experience | 19 Years |
Location | 80th St & 41st Ave, Elmhurst, New York |
Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1659442366 | NPI | - | NPPES |
00246075 | Medicaid | NY |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
367500000X | Nurse Anesthetist, Certified Registered | 517696 (New York) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
New York-presbyterian Hospital | New york, NY | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Singular Anesthesia Services Pllc | 7618284092 | 48 |
News Archive
Having studied the ethical, judicial and political arguments, the Norwegian government task force has suggested that a single nationwide company should be formed to commercialise biomaterials assets from the country's various sources. The task force has also recommended HUNT Biosciences be a model for the national company.
mtm laboratories, a privately held diagnostics company developing, manufacturing and globally commercializing in vitro diagnostics for cervical cancer early detection and diagnosis, today announced the signing for an additional tranche of Euro 7 million to its Series C funding. This addition is a formal expansion of the Company's last Series C in March 2008 and increases the total for the round to Euro 39 million (USD 57 million) in equity.
In March 2020, just weeks into the Covid-19 pandemic, the incident command center at Brigham and Women's Hospital in Boston was scrambling to understand this deadly new disease. It appeared to be killing more Black and brown patients than whites. For Latinos, there was an additional warning sign: language.
Johns Hopkins researchers examine the 20-year decline in male circumcision rates and assert it could raise medical costs related to sexually transmitted diseases and other health problems.
› Verified 4 days ago
Entity Name | Long Island Anesthesia Physicians Llp |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1952387276 PECOS PAC ID: 7113825381 Enrollment ID: O20040106000103 |
News Archive
Having studied the ethical, judicial and political arguments, the Norwegian government task force has suggested that a single nationwide company should be formed to commercialise biomaterials assets from the country's various sources. The task force has also recommended HUNT Biosciences be a model for the national company.
mtm laboratories, a privately held diagnostics company developing, manufacturing and globally commercializing in vitro diagnostics for cervical cancer early detection and diagnosis, today announced the signing for an additional tranche of Euro 7 million to its Series C funding. This addition is a formal expansion of the Company's last Series C in March 2008 and increases the total for the round to Euro 39 million (USD 57 million) in equity.
In March 2020, just weeks into the Covid-19 pandemic, the incident command center at Brigham and Women's Hospital in Boston was scrambling to understand this deadly new disease. It appeared to be killing more Black and brown patients than whites. For Latinos, there was an additional warning sign: language.
Johns Hopkins researchers examine the 20-year decline in male circumcision rates and assert it could raise medical costs related to sexually transmitted diseases and other health problems.
› Verified 4 days ago
Entity Name | North American Partners In Anesthesia Llp |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1649264706 PECOS PAC ID: 7719885771 Enrollment ID: O20040108000176 |
News Archive
Having studied the ethical, judicial and political arguments, the Norwegian government task force has suggested that a single nationwide company should be formed to commercialise biomaterials assets from the country's various sources. The task force has also recommended HUNT Biosciences be a model for the national company.
mtm laboratories, a privately held diagnostics company developing, manufacturing and globally commercializing in vitro diagnostics for cervical cancer early detection and diagnosis, today announced the signing for an additional tranche of Euro 7 million to its Series C funding. This addition is a formal expansion of the Company's last Series C in March 2008 and increases the total for the round to Euro 39 million (USD 57 million) in equity.
In March 2020, just weeks into the Covid-19 pandemic, the incident command center at Brigham and Women's Hospital in Boston was scrambling to understand this deadly new disease. It appeared to be killing more Black and brown patients than whites. For Latinos, there was an additional warning sign: language.
Johns Hopkins researchers examine the 20-year decline in male circumcision rates and assert it could raise medical costs related to sexually transmitted diseases and other health problems.
› Verified 4 days ago
Entity Name | New York University |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1851456701 PECOS PAC ID: 1355232422 Enrollment ID: O20040329001569 |
News Archive
Having studied the ethical, judicial and political arguments, the Norwegian government task force has suggested that a single nationwide company should be formed to commercialise biomaterials assets from the country's various sources. The task force has also recommended HUNT Biosciences be a model for the national company.
mtm laboratories, a privately held diagnostics company developing, manufacturing and globally commercializing in vitro diagnostics for cervical cancer early detection and diagnosis, today announced the signing for an additional tranche of Euro 7 million to its Series C funding. This addition is a formal expansion of the Company's last Series C in March 2008 and increases the total for the round to Euro 39 million (USD 57 million) in equity.
In March 2020, just weeks into the Covid-19 pandemic, the incident command center at Brigham and Women's Hospital in Boston was scrambling to understand this deadly new disease. It appeared to be killing more Black and brown patients than whites. For Latinos, there was an additional warning sign: language.
Johns Hopkins researchers examine the 20-year decline in male circumcision rates and assert it could raise medical costs related to sexually transmitted diseases and other health problems.
› Verified 4 days ago
Entity Name | Upstate Anesthesia Services, P.c. |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1629272141 PECOS PAC ID: 0840383857 Enrollment ID: O20070907000237 |
News Archive
Having studied the ethical, judicial and political arguments, the Norwegian government task force has suggested that a single nationwide company should be formed to commercialise biomaterials assets from the country's various sources. The task force has also recommended HUNT Biosciences be a model for the national company.
mtm laboratories, a privately held diagnostics company developing, manufacturing and globally commercializing in vitro diagnostics for cervical cancer early detection and diagnosis, today announced the signing for an additional tranche of Euro 7 million to its Series C funding. This addition is a formal expansion of the Company's last Series C in March 2008 and increases the total for the round to Euro 39 million (USD 57 million) in equity.
In March 2020, just weeks into the Covid-19 pandemic, the incident command center at Brigham and Women's Hospital in Boston was scrambling to understand this deadly new disease. It appeared to be killing more Black and brown patients than whites. For Latinos, there was an additional warning sign: language.
Johns Hopkins researchers examine the 20-year decline in male circumcision rates and assert it could raise medical costs related to sexually transmitted diseases and other health problems.
› Verified 4 days ago
Entity Name | Weill Medical College Of Cornell |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1164768305 PECOS PAC ID: 6800709023 Enrollment ID: O20130308000455 |
News Archive
Having studied the ethical, judicial and political arguments, the Norwegian government task force has suggested that a single nationwide company should be formed to commercialise biomaterials assets from the country's various sources. The task force has also recommended HUNT Biosciences be a model for the national company.
mtm laboratories, a privately held diagnostics company developing, manufacturing and globally commercializing in vitro diagnostics for cervical cancer early detection and diagnosis, today announced the signing for an additional tranche of Euro 7 million to its Series C funding. This addition is a formal expansion of the Company's last Series C in March 2008 and increases the total for the round to Euro 39 million (USD 57 million) in equity.
In March 2020, just weeks into the Covid-19 pandemic, the incident command center at Brigham and Women's Hospital in Boston was scrambling to understand this deadly new disease. It appeared to be killing more Black and brown patients than whites. For Latinos, there was an additional warning sign: language.
Johns Hopkins researchers examine the 20-year decline in male circumcision rates and assert it could raise medical costs related to sexually transmitted diseases and other health problems.
› Verified 4 days ago
Entity Name | Singular Anesthesia Services Pllc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1881086718 PECOS PAC ID: 7618284092 Enrollment ID: O20150917000516 |
News Archive
Having studied the ethical, judicial and political arguments, the Norwegian government task force has suggested that a single nationwide company should be formed to commercialise biomaterials assets from the country's various sources. The task force has also recommended HUNT Biosciences be a model for the national company.
mtm laboratories, a privately held diagnostics company developing, manufacturing and globally commercializing in vitro diagnostics for cervical cancer early detection and diagnosis, today announced the signing for an additional tranche of Euro 7 million to its Series C funding. This addition is a formal expansion of the Company's last Series C in March 2008 and increases the total for the round to Euro 39 million (USD 57 million) in equity.
In March 2020, just weeks into the Covid-19 pandemic, the incident command center at Brigham and Women's Hospital in Boston was scrambling to understand this deadly new disease. It appeared to be killing more Black and brown patients than whites. For Latinos, there was an additional warning sign: language.
Johns Hopkins researchers examine the 20-year decline in male circumcision rates and assert it could raise medical costs related to sexually transmitted diseases and other health problems.
› Verified 4 days ago
Mailing Address | Practice Location Address |
---|---|
Mrs Chhanda Beckford, CRNA 17506 Devonshire Rd Apt 6a, Jamaica, NY 11432-2914 Ph: (718) 206-4969 | Mrs Chhanda Beckford, CRNA 80th St & 41st Ave, Elmhurst, NY 11373-1329 Ph: (718) 334-5970 |
News Archive
Having studied the ethical, judicial and political arguments, the Norwegian government task force has suggested that a single nationwide company should be formed to commercialise biomaterials assets from the country's various sources. The task force has also recommended HUNT Biosciences be a model for the national company.
mtm laboratories, a privately held diagnostics company developing, manufacturing and globally commercializing in vitro diagnostics for cervical cancer early detection and diagnosis, today announced the signing for an additional tranche of Euro 7 million to its Series C funding. This addition is a formal expansion of the Company's last Series C in March 2008 and increases the total for the round to Euro 39 million (USD 57 million) in equity.
In March 2020, just weeks into the Covid-19 pandemic, the incident command center at Brigham and Women's Hospital in Boston was scrambling to understand this deadly new disease. It appeared to be killing more Black and brown patients than whites. For Latinos, there was an additional warning sign: language.
Johns Hopkins researchers examine the 20-year decline in male circumcision rates and assert it could raise medical costs related to sexually transmitted diseases and other health problems.
› Verified 4 days ago
Lynn Rossini, CRNA Nurse Anesthetist - CR Medicare: Not Enrolled in Medicare Practice Location: 90-02 Queens Blvd, Elmhurst, NY 11373 Phone: 718-558-1000 | |
Sharon Yvonne Thompson, RN Nurse Anesthetist - CR Medicare: May Accept Medicare Assignments Practice Location: 7901 Broadway, Suite E2-69, Elmhurst, NY 11373 Phone: 718-334-2880 Fax: 718-334-2399 | |
Roopnarine Rampersaud, Nurse Anesthetist - CR Medicare: Not Enrolled in Medicare Practice Location: 9002 Queens Blvd, Elmhurst, NY 11373 Phone: 718-558-1870 | |
Anne Marie Khouri, CRNA Nurse Anesthetist - CR Medicare: Not Enrolled in Medicare Practice Location: 9002 Queens Blvd, Elmhurst, NY 11373 Phone: 718-558-1000 | |
Ethelia Mckay, Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 9002 Queens Blvd, Elmhurst, NY 11373 Phone: 718-558-1870 | |
Lorinda Sherwood, LCSW Nurse Anesthetist - CR Medicare: Not Enrolled in Medicare Practice Location: 80th St & 41st Ave, Elmhurst, NY 11373 Phone: 718-334-5970 Fax: 718-334-5958 |